16-1193557-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_021098.3(CACNA1H):c.300-1415T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.847 in 152,336 control chromosomes in the GnomAD database, including 54,806 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.85 ( 54806 hom., cov: 38)
Consequence
CACNA1H
NM_021098.3 intron
NM_021098.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.80
Publications
4 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.956 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.300-1415T>C | intron_variant | Intron 2 of 34 | 1 | NM_021098.3 | ENSP00000334198.7 | |||
| CACNA1H | ENST00000569107.6 | c.300-1415T>C | intron_variant | Intron 2 of 33 | 1 | ENSP00000454990.2 | ||||
| CACNA1H | ENST00000711493.1 | c.300-1415T>C | intron_variant | Intron 2 of 33 | ENSP00000518778.1 | |||||
| CACNA1H | ENST00000565831.7 | c.300-1415T>C | intron_variant | Intron 2 of 33 | 1 | ENSP00000455840.1 | ||||
| CACNA1H | ENST00000711450.1 | c.300-1415T>C | intron_variant | Intron 2 of 34 | ENSP00000518762.1 | |||||
| CACNA1H | ENST00000564231.6 | c.300-1415T>C | intron_variant | Intron 2 of 34 | 1 | ENSP00000457555.2 | ||||
| CACNA1H | ENST00000638323.1 | c.300-1415T>C | intron_variant | Intron 2 of 34 | 5 | ENSP00000492267.1 | ||||
| CACNA1H | ENST00000562079.6 | c.300-1415T>C | intron_variant | Intron 2 of 33 | 1 | ENSP00000454581.2 | ||||
| CACNA1H | ENST00000711438.1 | c.300-1415T>C | intron_variant | Intron 2 of 33 | ENSP00000518754.1 | |||||
| CACNA1H | ENST00000711482.1 | c.300-1415T>C | intron_variant | Intron 2 of 35 | ENSP00000518771.1 | |||||
| CACNA1H | ENST00000711485.1 | c.300-1415T>C | intron_variant | Intron 2 of 34 | ENSP00000518774.1 | |||||
| CACNA1H | ENST00000711455.1 | c.300-1415T>C | intron_variant | Intron 2 of 35 | ENSP00000518768.1 | |||||
| CACNA1H | ENST00000711483.1 | c.300-1415T>C | intron_variant | Intron 2 of 34 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.300-1415T>C | intron_variant | Intron 2 of 33 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000621827.2 | n.300-1415T>C | intron_variant | Intron 2 of 36 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.300-1415T>C | intron_variant | Intron 2 of 33 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.300-1415T>C | intron_variant | Intron 2 of 34 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.300-1415T>C | intron_variant | Intron 2 of 34 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.300-1415T>C | intron_variant | Intron 2 of 33 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.300-1415T>C | intron_variant | Intron 2 of 35 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.300-1415T>C | intron_variant | Intron 2 of 34 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.300-1415T>C | intron_variant | Intron 2 of 35 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.300-1415T>C | intron_variant | Intron 2 of 35 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.300-1415T>C | intron_variant | Intron 2 of 35 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.300-1415T>C | intron_variant | Intron 2 of 34 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.300-1415T>C | intron_variant | Intron 2 of 36 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.300-1415T>C | intron_variant | Intron 2 of 35 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.300-1415T>C | intron_variant | Intron 2 of 34 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.847 AC: 128884AN: 152218Hom.: 54753 Cov.: 38 show subpopulations
GnomAD3 genomes
AF:
AC:
128884
AN:
152218
Hom.:
Cov.:
38
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.847 AC: 129001AN: 152336Hom.: 54806 Cov.: 38 AF XY: 0.849 AC XY: 63213AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
129001
AN:
152336
Hom.:
Cov.:
38
AF XY:
AC XY:
63213
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
37397
AN:
41586
American (AMR)
AF:
AC:
13251
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
2646
AN:
3470
East Asian (EAS)
AF:
AC:
5075
AN:
5186
South Asian (SAS)
AF:
AC:
3827
AN:
4824
European-Finnish (FIN)
AF:
AC:
9154
AN:
10622
Middle Eastern (MID)
AF:
AC:
239
AN:
294
European-Non Finnish (NFE)
AF:
AC:
54942
AN:
68024
Other (OTH)
AF:
AC:
1748
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1072
2144
3216
4288
5360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3043
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.